Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia

Nature Biotechnology
H BaronH Schuster

Abstract

More than half of all deaths in Western society are related to arteriosclerotic cardiovascular diseases. Inherited disturbances in the low-density-lipoprotein (LDL) receptor and similar lipid-related defects account for the majority of these deaths. Testing procedures thus far rely on total cholesterol, LDL cholesterol, high-density-lipoprotein cholesterol, and triglyceride determinations. These tests are not able to provide any genetic information. We have developed an oligonucleotide ligation assay (OLA) that enables us to screen for high-risk individuals by testing for 19 common mutations in the LDL receptor and the apolipoprotein B genes using an automated genotyping-based two-step protocol. The novel OLA uses oligomeric pentaethyleneoxide mobility modifiers. The automated test will be useful in screening large populations for genetic data to distinguish relative from absolute risk, as well as for cost-effective familial analysis.

References

Jan 1, 1992·Human Mutation·H H HobbsJ L Goldstein
Jan 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·F Barany
Jul 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·H SchusterN Zöllner
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D A NickersonU Landegren
Jan 1, 1971·Annals of Internal Medicine·W B KannelP M McNamara
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·P T KovanenM S Brown
Dec 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·H SchusterN Zöllner

❮ Previous
Next ❯

Citations

Sep 28, 2001·Journal of Clinical Laboratory Analysis·A D HorvathV S Ganev
Feb 17, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Friedrich C Luft
Jun 5, 2004·Atherosclerosis·Fernando Civeira, UNKNOWN International Panel on Management of Familial Hypercholesterolemia
Apr 6, 1999·The American Journal of Cardiology·T BoeckelH Schuster
Jan 22, 2003·Atherosclerosis·Ursula LoggenFriedrich C Luft
Apr 27, 2002·Atherosclerosis. Supplements·Herbert Schuster
Oct 1, 1996·Nature Biotechnology·I Day, S Humphries
Jun 2, 1998·Kidney International·H SchusterF C Luft
Mar 21, 2001·Biotechnology & Genetic Engineering Reviews·J W HollowayI N Day
Oct 27, 2009·Nucleic Acids Research·Joohoon Kim, Milan Mrksich
Oct 30, 2009·Nucleic Acids Research·Kyu-Han KimKyu-Won Kim
Apr 29, 1998·Current Opinion in Lipidology·A K Soutar
Jul 24, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·J GeiselK Wielckens
Sep 25, 1999·Journal of Neuroimmunology·J ChatawayA Compston
May 6, 2004·The Journal of Pediatrics·Craig A JefferiesWayne S Cutfield
Jan 20, 1999·European Journal of Clinical Investigation·X Pintó
May 21, 2004·Expert Review of Cardiovascular Therapy·Alpo F VuorioHelena Gylling
Nov 9, 2004·Chembiochem : a European Journal of Chemical Biology·Kazuhiko Nakatani
Jun 2, 2006·Angewandte Chemie·Shinzi Ogasawara, Kenzo Fujimoto
Oct 13, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·G FeriottoR Gambari
Nov 4, 2004·Human Mutation·George V Z DedoussisJanine Genschel
Jul 17, 1999·Journal of Inherited Metabolic Disease·D Ravine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.